Pia Österlund
Adjunct Professor
E-mail: pia.osterlund@ki.se
Visiting address: J6:20 BioClinicum, Akademiska stråket 1, 17164 Solna
Postal address: K7 Onkologi-Patologi, K7 Forskning Östman, 171 77 Stockholm
About me
- Adjunct Professor of Colorectal Cancer at the Department of
Oncology-Pathology as of 1 February 2021. Primary position: Consultant at
Karolinska University Hospital Consultant at Tampere University Hospital
Research
- Pia Österlund is an oncologist and studies ways to ensure that patients with
gastrointestinal cancer receive more effective treatment and enjoy a higher
quality of life. One important line of research is biomarkers that can help
doctors select the right treatments for their patients. Österlund is also
evaluating the relationship between diet, gut microbiome and adverse events
to understand why such events arise and how they can be alleviated. Amongst
other achievements, she has shown that the dominant colorectal cancer drug
often causes secondary lactose intolerance and that patients feel better if
their diet is adjusted accordingly.
In one current study, Österlund and her colleagues have shown that it is
possible using optimised treatment and centralised multidisciplinary team
assessment to operate metasta- tic colorectal cancers with excellent
outcomes. She has been principal investigator for many clinical studies on
new drugs and will in the future be involved in research on new potential
drug targets.
Articles
- Article: INTERNATIONAL JOURNAL OF CANCER. 2024;154(3):488-503
- Article: CLINICAL NUTRITION ESPEN. 2023;57:364-374
- Article: CANCERS. 2023;15(13):3398
- Article: JOURNAL OF CLINICAL MEDICINE. 2023;12(10):3541
- Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023;24(7):6753
- Article: ANNALS OF ONCOLOGY. 2023;34(1):10-32
- Article: JOURNAL OF GERIATRIC ONCOLOGY. 2023;14(1):101408
- Article: BRITISH JOURNAL OF CANCER. 2022;127(4):686-694
- Article: HEALTHCARE. 2022;10(9):1618
- Article: CANCER TREATMENT AND RESEARCH COMMUNICATIONS. 2022;31:100517
- Article: FRONTIERS IN NUTRITION. 2022;9:1030619
- Article: FRONTIERS IN ONCOLOGY. 2022;12:826073
- Article: ESMO OPEN. 2021;6(6):100219
- Article: CANCERS. 2021;13(15):3892
- Article: BRITISH JOURNAL OF SURGERY. 2021;108(7):817-825
- Article: JCO ONCOLOGY PRACTICE. 2021;17(7):442-e998
- Article: LANCET REGIONAL HEALTH-EUROPE. 2021;3:100049
- Article: ACTA ONCOLOGICA. 2020;59(12):1416-1423
- Article: NUTRIENTS. 2020;12(2):E407-407
- Article: ANNALS OF ONCOLOGY. 2020;31(2):246-256
- Article: PLOS ONE. 2020;15(12):e0243900
- Article: PLOS ONE. 2020;15(11):e0239819
- Article: PLOS ONE. 2020;15(8):e0236569
- Article: SCANDINAVIAN JOURNAL OF SURGERY. 2019;108(3):201-209
- Article: TRANSLATIONAL ONCOLOGY. 2019;12(8):1122-1130
- Article: LANCET GASTROENTEROLOGY & HEPATOLOGY. 2019;4(5):376-388
- Article: ACTA ONCOLOGICA. 2019;58(4):398-406
- Article: FRONTIERS IN NUTRITION. 2019;6:22
- Article: ACTA ONCOLOGICA. 2018;57(6):750-758
- Article: TUMOR BIOLOGY. 2018;40(1):1010428317752944-101042831775294
- Article: EJSO. 2017;43(9):1682-1689
- Article: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2017;80(2):317-332
- Article: ACTA OTO-LARYNGOLOGICA. 2017;137(7):778-785
- Article: BRITISH JOURNAL OF CANCER. 2017;116(10):1271-1278
- Article: INTERNATIONAL JOURNAL OF CANCER. 2017;140(4):922-929
- Article: PLOS ONE. 2017;12(11):e0187667
- Article: NEUROLOGY. 2016;87(22):2290-2299
- Article: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2016;78(4):863-874
- Article: ANNALS OF ONCOLOGY. 2016;27(8):1386-1422
- Article: ANNALS OF SURGICAL ONCOLOGY. 2016;23(5):1721-1728
- Article: SUPPORTIVE CARE IN CANCER. 2015;23(6):1495-1502
- Article: LANCET ONCOLOGY. 2015;16(5):499-508
- Article: EUROPEAN JOURNAL OF CANCER. 2014;50(17):2966-2974
- Article: NEUROGASTROENTEROLOGY AND MOTILITY. 2014;26(8):1179-1187
- Article: CLINICAL CANCER RESEARCH. 2014;20(12):3338-3347
- Article: ONCOLOGY LETTERS. 2014;7(2):553-559
- Article: PLOS ONE. 2014;9(6):e99590
- Article: ONCOTARGETS AND THERAPY. 2014;7:1177-1184
- Article: ANTICANCER RESEARCH. 2013;33(1):253-260
- Article: JOURNAL OF CLINICAL GASTROENTEROLOGY. 2013;47(1):45-51
- Article: LANCET ONCOLOGY. 2013;14(1):29-37
- Article: ANNALS OF ONCOLOGY. 2013;24(1):152-160
- Article: CANCER GENETICS. 2012;205(11):545-551
- Article: HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK. 2012;34(10):1450-1455
- Article: INTERNATIONAL JOURNAL OF COLORECTAL DISEASE. 2012;27(2):171-178
- Article: SCANDINAVIAN JOURNAL OF SURGERY. 2012;101(4):275-282
- Article: GENES CHROMOSOMES & CANCER. 2012;51(1):1-9
- Article: BRITISH JOURNAL OF CANCER. 2011;104(4):599-604
- Article: INTERNATIONAL JOURNAL OF CANCER. 2007;121(9):2052-2059
- Article: BRITISH JOURNAL OF CANCER. 2007;97(8):1028-1034
- Article: ACTA ONCOLOGICA. 2005;44(3):203-217
- Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2004;2(8):696-703
- Article: BRITISH JOURNAL OF CANCER. 2002;87(6):591-599
- Article: ONCOLOGY. 2001;61(2):113-119
- Show more
All other publications
- Letter: JOURNAL OF GERIATRIC ONCOLOGY. 2024;15(2):101632
- Corrigendum: CLINICAL NUTRITION ESPEN. 2023;58:421-423
- Editorial comment: BRITISH JOURNAL OF SURGERY. 2023;110(8):931-935
- Other: CASE REPORTS IN ONCOLOGY. 2021;14(3):1475-1482
- Letter: LANCET REGIONAL HEALTH-EUROPE. 2021;5:100135
- Letter: ACTA ONCOLOGICA. 2020;59(12):1503-1507
- Editorial comment: SEMINARS IN ONCOLOGY. 2017;44(2):129-131
- Letter: JOURNAL OF CLINICAL ONCOLOGY. 2017;35(2):254-255
- Editorial comment: ANNALS OF ONCOLOGY. 2016;27(8):1378-1381
- Review: TARGETED ONCOLOGY. 2016;11(3):293-308
- Review: ESMO OPEN. 2016;1(5):e000097
- Editorial comment: ESMO OPEN. 2016;1(1):e000004
- Meeting abstract: JOURNAL OF CLINICAL ONCOLOGY. 2014;32(3):520
- Review: SCANDINAVIAN JOURNAL OF SURGERY. 2011;100(1):35-41
- Letter: ANNALS OF ONCOLOGY. 2009;20(2):393-394